Rockbridge Investment Management, Lcc Sangamo Therapeutics, Inc Transaction History

Rockbridge Investment Management, Lcc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.3 - $0.63 $271 - $570	-905 Closed	0 $0
Q3 2022 May 28, 2024	SELL	$4.27 - $6.39 $3,864 - $5,782	-905 Closed	0 $0
Q1 2022 May 28, 2024	BUY	$5.23 - $7.82 $4,733 - $7,077	905 New	905 $5,000
Q3 2021 Nov 12, 2021	SELL	$9.01 - $12.01 $540 - $720	-60 Reduced 6.22%	905 $8,000
Q4 2020 Mar 04, 2021	BUY	$9.23 - $18.18 $553 - $1,090	60 Added 6.63%	965 $15,000
Q2 2020 Aug 20, 2020	BUY	$6.21 - $11.83 $5,620 - $10,706	905 New	905 $8,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $160M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.